circKIF4A was overexpressed in glioma, and knockdown of circKIF4A suppressed glioma progression via miR-139-3p/Wnt5a axis. The results indicated that circKIF4A may be a potential target for clinical treatment of glioma.
circKIF4A promotes tumorogenesis of glioma by targeting miR-139-3p to activate Wnt5a signaling.